Lesion formation is absent following injection of rAbs MS#30 and ON#34 with HC into PLP1y/– animals, confirming PLP1 as a bona fide pathogenic antigenic target that provides a putative identity to the IgG demyelinating activity described in some MS patients (25–27). Here, PLP1 is linked to myeloid sarcoma.